Ftse Mib
33.766,29
-0,06%
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
1,03%
Bitcoin
96.817,59
-0,40%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Tonix Pharmaceuticals Holding Corporation (TNXP) Tonix Pharmaceuticals Holding Corporation (TNXP) Notizie

Tonix Pharmaceuticals Holding Corporation

TNXP
0,5155
-0,0545 (-9,56%)
21 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/12/202422:17EDGAR2Form 8-K - Current report
20/12/202422:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/12/202415:25APSThis Micro Cap Is Getting Bid Up Prior To Opening Bell
17/12/202414:05EDGAR2Form 8-K - Current report
17/12/202414:00GLOBETonix Pharmaceuticals Announces FDA Acceptance of the New..
06/12/202422:13EDGAR2Form S-8 - Securities to be offered to employees in employee..
03/12/202413:05EDGAR2Form 8-K - Current report
03/12/202413:00GLOBETonix Pharmaceuticals Announces Expansion of Leadership Team..
26/11/202413:00GLOBETonix Pharmaceuticals to Participate in the NobleCon20..
18/11/202422:05GLOBETonix Pharmaceuticals to Present at the Winter 2024 Investor..
18/11/202413:00GLOBETonix Pharmaceuticals Presented Data and Analyses of TNX-102..
14/11/202422:42EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
13/11/202422:05GLOBETonix Pharmaceuticals Announces Poster Presentation at the..
13/11/202415:10EDGAR2Form 8-K - Current report
13/11/202415:05GLOBETonix Pharmaceuticals Announces Peer-Reviewed Publication in..
12/11/202423:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202414:05EDGAR2Form 8-K - Current report
12/11/202414:00GLOBETonix Pharmaceuticals Reports Third Quarter 2024 Financial..
08/11/202423:15EDGAR2Form 8-K - Current report
04/11/202413:30EDGAR2Form 8-K - Current report
04/11/202413:00GLOBETonix Pharmaceuticals Announces Research Agreement with..
01/11/202412:05EDGAR2Form 8-K - Current report
01/11/202412:00GLOBETonix Pharmaceuticals Presented Data on Potential Mpox..
30/10/202421:30EDGAR2Form 8-K - Current report
29/10/202413:00GLOBETonix Pharmaceuticals to Present at BIO-Europe® 2024
28/10/202422:16EDGAR2Form 8-K - Current report
25/10/202414:00GLOBETonix Pharmaceuticals to Present at the 2024 ThinkEquity..
24/10/202414:00GLOBETonix Pharmaceuticals Announces Oral Presentation at the..
17/10/202414:05EDGAR2Form 8-K - Current report
17/10/202414:00GLOBETonix Pharmaceuticals Receives First Contract Payment from..
16/10/202415:01EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
16/10/202414:05EDGAR2Form 8-K - Current report
16/10/202414:00GLOBETonix Pharmaceuticals Announces Submission of the TNX-102 SL..
08/10/202414:30GLOBETonix Pharmaceuticals Announces AI Collaboration with X-Chem..
08/10/202413:05EDGAR2Form 8-K - Current report
01/10/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
30/9/202413:00GLOBETonix Pharmaceuticals Announces Participation in Endpoints..
27/9/202413:05EDGAR2Form 8-K - Current report
27/9/202413:00GLOBETonix Pharmaceuticals Announces Issuance of U.S. Patent..
23/9/202423:09EDGAR2Form DEF 14A - Other definitive proxy statements
23/9/202413:08EDGAR2Form 8-K - Current report
23/9/202413:00GLOBETonix Pharmaceuticals Announces Data Presentations on..
20/9/202423:03EDGAR2Form S-3 - Registration statement under Securities Act of..
19/9/202413:05EDGAR2Form 8-K - Current report
19/9/202413:00GLOBETonix Pharmaceuticals Announces Issuance of U.S. Patent by..
16/9/202413:23EDGAR2Form 8-K - Current report
16/9/202413:00GLOBETonix Pharmaceuticals Announces That its Single Dose Mpox..
13/9/202423:00EDGAR2Form PRE 14A - Other preliminary proxy statements
10/9/202413:05EDGAR2Form 8-K - Current report
10/9/202413:00GLOBETonix Pharmaceuticals Announces Appointment of Thomas..
Apertura: 0,5619 Min: 0,5348 Max: 0,6999
Chiusura: 0,57

La tua Cronologia

NASDAQ
TNXP
Tonix Pharmaceuticals
BIT
I05821
Banca Imi
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network